Tianjin Bofield Technology Co., Ltd., established on 2010-11-16, Business scope includes research and development of feed and feed additives;feed,Feed additives,Mixed Feed Additives,additive premixed feed,Enzymes for Papermaking,enzymes for washing,Textile,Enzymes for washing,leather(fur)Produced with enzymes,Sales;Wholesale and retail of food additives;Biotechnology R&D,Serve,consult,transfer,to promote;Conference Services(Does not include venue services);Undertake exhibition display service(Does not include venue services);Import and export of goods or technology(Except for the import and export of goods or technologies that are prohibited by the state or involve approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Challenge Bio-Technology Co. Ltd., part of The Hartcourt Cos., Inc., is a company headquartered in Beijing, China. The firm manufactures enzymes and probiotics.

Taiyi and Pu (Beijing) Chinese Medicine Research Institute Co., Ltd., established on 1996-11-25, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Organize cultural and artistic exchange activities(Except for performances);SalesIclass of medical devices,cosmetic;sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

Efamol Ltd., a subsidiary of Infinitus Holdings (Pty) Ltd., is a company headquartered in Hessle, UK, that produces and sells food supplements through online. It was founded in 1977 by David Horrobin. On November 01, 1998 Nutricia Holdings Plc acquired Efamol Ltd. from Scotia Holdings Plc for $27.12 million.\nThe company says this about itself: Efamol specialises in essential fatty acid (EFAs) based products, the so called \"good fats\" that are essential for the healthy functioning of every cell in the human body. These \"good fats\" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil.

Researches and develops bio-pharmaceuticals

Ripple (Tianjin) Biopharmaceutical Co., Ltd., established on 1998-08-03, Business scope includes biotechnology development,consult,Serve;powder injection,powder/Powder(Contains Chinese herbal extracts)/Premix,tablet/Granules(Contains Chinese herbal extracts),Terminally sterilized small volume injection(Contains Chinese herbal extracts),Terminally Sterilized Bulk Non-intravenous Injectables(Contains Chinese herbal extracts),Non-terminal sterilized large volume injection,ointment,ear drops,Sterile API(Ceftiofur),oral solution(Contains Chinese herbal extracts),disinfectant/insecticide/Transdermal agent(liquid),Feed additives,Additive premix feed production and sales;Engage in import and export business permitted by national laws and regulations;Animal Cleaning Products(except medicines),Production and sales of external animal care products;Agricultural product acquisition;General cargo.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Kekang Stem Cell Technology Co., Ltd., established on 2014-07-30, Business scope includes general business items:Science and Technology Information Consulting;Biological product,Bioengineering Technology Development and Consulting;Instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals)promotion of;Sales of Class I Medical Devices.Operating e-commerce,database service,database management;Agricultural Technology,Biotechnology,new material technology,Promotion of Energy Saving Technology;Technical development of biological products;Technology development of biotechnology products;Cosmetic sales;Domestic Trade,Import and export of goods and technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);hospital management;R&D and application of cell technology;Human stem cell technology development and application.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:stem cell test;clinical body fluid test;blood test;clinical microbiology test;clinical chemistry test.Sales of Class II Medical Devices;Maternal and Child Services,Pension Service;Medical diagnosis and treatment;Sales of health food.;Outpatient setting,Practice registration and change;Class III medical device business;food circulation;Maternal and Child Services(Confinement service),Pension Service;medical service;Various construction activities;Medical beauty service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Tianjin Shengji Group Co., Ltd., established on 1998-10-21, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Veterinary drug business;Disinfectant sales(Free of Hazardous Chemicals);Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;fertilizer sales;Retailing of protective equipment for healthcare workers;Pet Food and Supplies Wholesale;Feed production special equipment sales;Refrigeration,Air Conditioning Equipment Sales;road freight transport(Does not contain dangerous goods)Non-residential real estate leases;property management;Machinery and Equipment Leasing;Car rental;Landscaping engineering construction;Import and export;Technology Import and Export;Grain Purchase;Purchase of primary agricultural products;Chinese herbal medicine acquisition.Limited to branch operations:Veterinary drug production;Disinfectant production(Free of Hazardous Chemicals);feed production;Feed additive production;Primary processing of non-edible agricultural products;fertilizer production;Manufacturing of bio-based materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Ruibet Technology Development Co., Ltd., established on 2007-09-18, Business scope includes biological,Medical Technology Development,consult,Serve,transfer,training.(The country has a special,Franchised,Execute according to regulations)

A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany.

Ruicheng County Weirfu Veterinary Medicine Co., Ltd., established on 2001-04-18, The business scope includes veterinary raw materials,veterinary medicine,feed,Feed additives,Production and sales of animal diagnostic kits;Manufacturing and sales of disinfectants;Chinese Herbal Medicine,Production and sales of Chinese herbal extracts;Animal Vaccine Sales;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kunshan Boqing Biotechnology Co., Ltd., established on 2006-12-29, The business scope includes the production of veterinary drugs(according to<Veterinary drug production license>Approved scope of operation);disinfection products(Enzyme biochemicals only,amino acids and proteins),medical dressing,food additives,Production of Feed Additives,Sales;cosmetic,hygiene products,Sales of pet food supplies;Biological enzymes,Antimicrobial Peptides,genetically engineered product,Research on gene diagnosis and treatment technology;Technology transfer of the aforementioned R&D achievements,technical consulting,Technical Services.(The law in the aforementioned business items,Administrative regulations stipulate pre-licensing operations,restricted operation,Except for prohibited operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Nanjing Zelang Pharmaceutical Technology Co., Ltd., established on 2015-03-19, Business scope includes medical technology research and development;primary agricultural products,Cosmetic sales;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)